Preventive Medicine, Addiction Medicine · Chattanooga, TN
NPI
1629234521
Since 2008
Specialty
Preventive Medicine, Addiction Medicine
Code 2083A0300X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
6141 Shallowford Rd Ste 100
Chattanooga, TN, 37421
Phone (423) 498-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
300 services
Medicare patients, 2024
32
Average age 54
Drug cost, 2024
$268K
1,394 prescriptions
Company payments, 2025
$24.14
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sanjivini V Jacob was code 80305 (drug tests), 120 times for 30 patients. In total Sanjivini V Jacob billed 300 services in 9 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80305 Drug Tests | Office | 120 | 30 | $12.35 | $1,482 |
| G2087 Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | Office | 106 | 26 | $305.28 | $32K |
| 99215 Office E&M - Established | Office | 28 | 12 | $115.62 | $3,237 |
By year: 2022 $27K for 236 services; 2023 $31K for 236 services; 2024 $39K for 300 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 120 | 30 | $12.35 | $1,482 |
Medicare prescription drug claims, 2024
In 2024, the drug Sanjivini V Jacob prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 1,057 prescriptions and refills. In total Sanjivini V Jacob wrote 1,394 Medicare prescriptions that cost $268K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 1,057 | 1,057 | 138 | $115K |
| Sublocade Buprenorphine | 53 | 53 | 12 | $109K |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 34 | 34 | Under 11 | $16K |
| Ondansetron Odt Ondansetron | 26 | 26 | 21 | $245 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 24 | 24 | Under 11 | $214 |
| Buprenorphine Hcl Generic | 21 | 21 | Under 11 | $531 |
| Clonazepam Generic | 20 | 20 | Under 11 | $159 |
| Venlafaxine Hcl Generic | 19 | 19 | Under 11 | $35.89 |
| Naloxone Hcl Generic | 18 | 18 | 17 | $994 |
| Aripiprazole Generic | 16 | 16 | Under 11 | $135 |
| Zubsolv Buprenorphine Hcl/Naloxone Hcl | 15 | 15 | Under 11 | $6,836 |
| Armodafinil Generic | 13 | 13 | Under 11 | $1,005 |
| Fluoxetine Hcl Generic | 13 | 13 | Under 11 | $32.04 |
| Ibuprofen Generic | 11 | 11 | Under 11 | $38.09 |
| Hydroxyzine Hcl Generic | 11 | 11 | Under 11 | $93.09 |
Brand drugs: 129 claims; generic drugs: 1,265 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sanjivini V Jacob $24.14 ($24.14 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $24.14.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $24.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.